| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |